JP2023525345A5 - - Google Patents
Info
- Publication number
- JP2023525345A5 JP2023525345A5 JP2022568961A JP2022568961A JP2023525345A5 JP 2023525345 A5 JP2023525345 A5 JP 2023525345A5 JP 2022568961 A JP2022568961 A JP 2022568961A JP 2022568961 A JP2022568961 A JP 2022568961A JP 2023525345 A5 JP2023525345 A5 JP 2023525345A5
- Authority
- JP
- Japan
- Prior art keywords
- lymphocytes
- hematopoietic tissue
- tissue sample
- interleukin
- culturing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2006989.4 | 2020-05-12 | ||
| GBGB2006989.4A GB202006989D0 (en) | 2020-05-12 | 2020-05-12 | Methods for isolating gamma delta t cells |
| PCT/GB2021/051144 WO2021229226A1 (en) | 2020-05-12 | 2021-05-12 | Methods for isolating gamma delta t cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023525345A JP2023525345A (ja) | 2023-06-15 |
| JP2023525345A5 true JP2023525345A5 (cg-RX-API-DMAC7.html) | 2024-05-23 |
Family
ID=71134832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568961A Pending JP2023525345A (ja) | 2020-05-12 | 2021-05-12 | ガンマデルタt細胞を単離する方法 |
Country Status (13)
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6028176A (en) | 1996-07-19 | 2000-02-22 | Bayer Corporation | High-affinity interleukin-4 muteins |
| CN101120083B (zh) | 2003-10-08 | 2013-03-27 | 威尔森沃尔夫制造公司 | 利用透气性材料进行细胞培养的方法及装置 |
| EP1777294A1 (en) | 2005-10-20 | 2007-04-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins |
| US20070122413A1 (en) | 2005-11-28 | 2007-05-31 | Sivakumar Pallavur V | Il-21 antagonists |
| US8617531B2 (en) | 2006-12-14 | 2013-12-31 | Bolder Biotechnology, Inc. | Methods of making proteins and peptides containing a single free cysteine |
| WO2012088446A1 (en) | 2010-12-22 | 2012-06-28 | Board Of Trustees Of The Leland Stanford Junior University | Superagonists and antagonists of interleukin-2 |
| UA123821C2 (uk) | 2014-06-11 | 2021-06-09 | Полібіосепт Гмбх | Композиція для експансії лімфоцитів in vitro |
| KR20240063197A (ko) * | 2015-06-09 | 2024-05-09 | 감마델타 테라퓨틱스 엘티디 | Tcr 감마 델타 양성 t 세포의 생산 방법 |
| JP6799895B2 (ja) * | 2015-06-09 | 2020-12-16 | リンファクト−リンフォサイト アクティベイション テクノロジーズ エス.エー. | TCRγδ+T細胞の生産方法 |
| CN108473958A (zh) * | 2015-10-30 | 2018-08-31 | 癌症研究技术有限公司 | 非造血组织驻留γδT细胞的扩增及这些细胞的用途 |
| CN118421557A (zh) * | 2016-05-12 | 2024-08-02 | 阿迪塞特治疗公司 | 选择性扩增γδT细胞群的方法及其组合物 |
| JOP20190224A1 (ar) * | 2017-03-29 | 2019-09-26 | Iovance Biotherapeutics Inc | عمليات من أجل إنتاج الخلايا اللمفاوية المرتشحة للأورام واستخداماتها في العلاج المناعي |
| GB201707048D0 (en) * | 2017-05-03 | 2017-06-14 | King S College London | Expansion of gamma delta cells, compositions, and methods of use thereof |
| JP7557367B2 (ja) * | 2017-11-17 | 2024-09-27 | アイオバンス バイオセラピューティクス,インコーポレイテッド | 細針吸引及び小生検からのtil拡大培養 |
| GB202002581D0 (en) * | 2020-02-24 | 2020-04-08 | Gammadelta Therapeutics Ltd | Novel antibodies |
-
2020
- 2020-05-12 GB GBGB2006989.4A patent/GB202006989D0/en not_active Ceased
-
2021
- 2021-05-12 MX MX2022014111A patent/MX2022014111A/es unknown
- 2021-05-12 CN CN202511225493.3A patent/CN121294340A/zh active Pending
- 2021-05-12 WO PCT/GB2021/051144 patent/WO2021229226A1/en not_active Ceased
- 2021-05-12 CN CN202180035561.3A patent/CN115667501B/zh active Active
- 2021-05-12 CA CA3183145A patent/CA3183145A1/en active Pending
- 2021-05-12 BR BR112022022939A patent/BR112022022939A2/pt unknown
- 2021-05-12 AU AU2021271222A patent/AU2021271222A1/en active Pending
- 2021-05-12 EP EP21727525.4A patent/EP4150055A1/en active Pending
- 2021-05-12 KR KR1020227041283A patent/KR20230010209A/ko active Pending
- 2021-05-12 IL IL298000A patent/IL298000A/en unknown
- 2021-05-12 US US17/998,766 patent/US20230227777A1/en active Pending
- 2021-05-12 JP JP2022568961A patent/JP2023525345A/ja active Pending
-
2022
- 2022-12-07 CO CONC2022/0017768A patent/CO2022017768A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MacDonald et al. | Methods to manufacture regulatory T cells for cell therapy | |
| JP2022506836A5 (cg-RX-API-DMAC7.html) | ||
| JP5101559B2 (ja) | invitroにおけるCD14陽性単球からの樹状細胞の産出 | |
| Ichikawa et al. | Hepatic stellate cells function as regulatory bystanders | |
| CN112458053B (zh) | 一种基于滋养层细胞的脐血Treg细胞体外扩增方法及应用 | |
| CA2122141C (en) | Methods for selectively expanding stem cells | |
| KR101732532B1 (ko) | 단구 또는 nk 세포를 입수하는 방법 | |
| EP3303569A1 (en) | Semi-static cell culture | |
| CN107164323A (zh) | 一种获得具高杀伤肿瘤细胞能力的淋巴细胞亚群的方法 | |
| CN112725267A (zh) | 一种pbmc和msc共培养的方法及其应用 | |
| CN110938595B (zh) | 一种高效体外培养脐血cik细胞的培养基及培养方法 | |
| CN112680415A (zh) | 一种nk培养基及其扩增培养方法 | |
| CN115094034B (zh) | 一种人nkt细胞系及其应用 | |
| Selvaraj et al. | Influence of HLA-DR2 phenotype on humoral immunity & lymphocyte response to Mycobacterium tuberculosis culture filtrate antigens in pulmonary tuberculosis | |
| CN108251370A (zh) | 非细胞来源的多肽致敏的dc-cik细胞、其构建方法及应用 | |
| Delles et al. | A simple method for the purification of human peripheral blood antigen presenting cells (dendritic cells, monocytes/macrophages, and B lymphocytes) | |
| CN108949686B (zh) | 一种在低氧环境中从胎盘中获取造血干细胞的方法 | |
| CN1244691C (zh) | 自体胸水上清培养til细胞的方法 | |
| CN113817683A (zh) | 一种肺癌类器官的培养基及其应用 | |
| CN113502268A (zh) | 一种树突状细胞的制备方法 | |
| RU2796356C9 (ru) | КЛЕТОЧНАЯ ЛИНИЯ АЛЬВЕОЛЯРНОЙ САРКОМЫ ЧЕЛОВЕКА 9927 AlS SIO | |
| CN119410582B (zh) | 干细胞样记忆性t淋巴细胞的培养基和培养方法 | |
| CN112858688A (zh) | Slamf7表达的cd4+t细胞在制备结核病诊断或治疗试剂中的应用 | |
| CN117736988B (zh) | 用于诱导Tscm细胞的培养基、培养方法及其应用 | |
| CN119082023A (zh) | 冻存脐带血造血干细胞来源的nk细胞的制备方法 |